Watch Ticker

Rocket Pharmaceuticals, Inc. Common Stock

Go to Rocket Pharmaceuticals, Inc. Common Stock Website

$3.03

-0.01 (-0.33%)

Live

Previous Close

$3.04

Day Range

$0 - $0

Previous Day Range

$2.97 - $3.13

Market Cap

$330.8 million USD

Day Vol.

Previous Day Vol.

2.1 million

Currency

USD

Primary Exchange

Nasdaq

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Pomerantz Llp - INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT

Pomerantz Law Firm filed a class action lawsuit against Rocket Pharmaceuticals after a patient death in a Phase 2 gene therapy trial, causing the stock to drop 62.84%.

Related tickers: RCKT, RCKTW.

Read Full Article

Hagens Berman - Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA’s Clinical Hold on Gene Therapy Trial – Hagens Berman

Rocket Pharmaceuticals faces a securities class action lawsuit after the FDA placed a clinical hold on its Phase 2 trial for RP-A501, a gene therapy for Danon disease, causing its stock to drop over 60% on May 27, 2025.

Related tickers: RCKT, RCKTW.

Read Full Article

Trending Tickers

Please sign in to view